05/27/2026
What if a simple blood test could help detect brain disorders like dementia, concussion and stroke?
A new research facility at UBC is helping make that future possible.
Led by Dr. Cheryl Wellington, the Core Facility for Neurology Biomarker Innovation (CFNBI) is advancing the development of blood biomarker tests for neurological diseases. These faster, less invasive and more accessible tools could help detect disease earlier and guide treatment decisions more precisely to improve patient outcomes.
Dr. Wellington and her team are already supporting collaborative research spanning Alzheimer’s disease, spinal cord injury, critical care medicine, pediatric brain health, wildfire smoke exposure and more.
By bringing together researchers, clinicians and partners, the CFNBI is accelerating the translation of biomarker discoveries from the lab to clinical care.
Read more: https://bit.ly/4tZ6Dne